Biogen, Inc. - Company Profile and SWOT Analysis
SummaryBiogen, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Biogen, Inc. (Biogen or 'the company') discovers, develops, manufactures and commercializes therapies in the areas of hematology, neurology and immunology. The company develops therapies for multiple sclerosis, neuroimmunology movement disorders, including Parkinson's disease, Alzheimer's disease and dementia, and neuromuscular disorders, including amyotrophic lateral sclerosis and spinal muscular atrophy. It also develops and manufactures biosimilars of advanced biologics. The company markets its products under Flixabi, Benepali, Imraldi, Spinraza, Tecfidera, Avonex, Tysabri, Eylea, Gazyva, Fampyra, Plegridy and Fumaderm brand names. Biogen has business operations in the North America, Asia and Europe. The company is headquartered in Weston, Massachusetts, the US.
Scope
- Detailed information on Biogen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
- Intelligence on Biogen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Biogen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of Biogen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Biogen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Biogen, Inc.'s business structure, strategy and prospects.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.